Literature DB >> 14669113

[Surgical treatment for hilar cholangiocarcinoma (Klatskin's tumor)].

T Becker1, F Lehner, H Bektas, A Meyer, R Lück, B Nashan, J Klempnauer.   

Abstract

Surgical treatment of hilar bile duct carcinoma remains difficult, which is due to the inadequate possibilities in assessing tumor extent during the preoperative diagnostic procedure as well as intraoperatively. Radical resection with negative histologic margins offers the best chance for long-term survival. The decision regarding the appropriate surgical approach is challenging due to the complexity of tumor localization and neighboring vascular structures. Aggressive resection demands extended liver resection, which is associated with the risk of postoperative liver failure. However, even limited surgery such as hilar resection can be curative and leads to long-term survival in individual cases. The principles of surgical oncology have led to more aggressive procedures, including the combination of liver transplantation and multivisceral resection, and can be performed with calculable morbidity and mortality. Nevertheless, the high risk of tumor recurrence under long-term immunosuppression, the limited availability of donor organs and the excellent results of liver transplantation in non-malignant diseases do not justify this procedure at present. Neoadjuvant radiochemotherapy has failed to demonstrate major benefit. In patients with irresectable tumor or distant metastases palliative measures are aimed at restoring an unobstructed bile flow with endoscopic placement of metal stents. Palliative treatment with additional radio- or photodynamic therapy may be considered in individual cases.

Entities:  

Mesh:

Year:  2003        PMID: 14669113     DOI: 10.1055/s-2003-44800

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  4 in total

1.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

2.  Radiofrequency ablation as a treatment for hilar cholangiocarcinoma.

Authors:  Wei-Jun Fan; Pei-Hong Wu; Liang Zhang; Jin-Hua Huang; Fu-Jun Zhang; Yang-Kui Gu; Ming Zhao; Xiang-Long Huang; Chang-Yu Guo
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

3.  Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.

Authors:  Jan Bednarsch; Jakob Kather; Xiuxiang Tan; Shivan Sivakumar; Claudio Cacchi; Georg Wiltberger; Zoltan Czigany; Florian Ulmer; Ulf Peter Neumann; Lara Rosaline Heij
Journal:  Liver Cancer       Date:  2021-05-06       Impact factor: 11.740

4.  Leakage and Stenosis of the Hepaticojejunostomy Following Surgery for Perihilar Cholangiocarcinoma.

Authors:  Jan Bednarsch; Zoltan Czigany; Daniel Heise; Sven Arke Lang; Steven W M Olde Damink; Tom Luedde; Philipp Bruners; Tom Florian Ulmer; Ulf Peter Neumann
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.